Insulet Initiates Voluntary Medical Device Correction for Certain Omnipod® 5 Pods in the U.S.Business Wire • 03/12/26
Insulet Presents Promising Study Results for Fully Closed-Loop Automated Insulin Delivery System for Adults with Type 2 DiabetesBusiness Wire • 03/11/26
Insulet to Present EVOLUTION 2 Results on Omnipod® Fully Closed-Loop System for Adults with Type 2 Diabetes at International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)Business Wire • 03/10/26
Insulet (PODD) Q4 Earnings: How Key Metrics Compare to Wall Street EstimatesZacks Investment Research • 02/18/26
Exploring Analyst Estimates for Insulet (PODD) Q4 Earnings, Beyond Revenue and EPSZacks Investment Research • 02/12/26
Insulet Launches Omnipod® 5 and Omnipod Discover™ in the Middle East to Transform Diabetes CareBusiness Wire • 02/05/26
Insulet Corporation (PODD) Presents at 44th Annual J.P. Morgan Healthcare Conference TranscriptSeeking Alpha • 01/13/26
Insulet to Announce Fourth Quarter and Full Year 2025 Financial Results on February 18, 2026Business Wire • 01/09/26
Insulet Redefines Diabetes at CES with "Liveable Technology" — A New Frontier in Human-Centered Connected HealthBusiness Wire • 01/06/26
Insulet Expands Omnipod® U.S. Recycling Program, Diverting Millions of Pods from Landfills and Creating a More Sustainable FutureBusiness Wire • 12/15/25